Skip to main content
Top
Published in: Acta Diabetologica 9/2019

01-09-2019 | Obesity | Original Article

Prediabetes defined by HbA1c and by fasting glucose: differences in risk factors and prevalence

Authors: Santiago Rodriguez-Segade, Javier Rodriguez, Félix Camiña, Luís Sanmartín-Portas, Josefa Gerpe-Jamardo, Marcos Pazos-Couselo, Jose M. García-López, Manuela Alonso-Sampedro, Arturo González-Quintela, Francisco Gude

Published in: Acta Diabetologica | Issue 9/2019

Login to get access

Abstract

Aims

To investigate, in a sample of nondiabetic adults from a Spanish community, the differences between prediabetes as defined by HbA1c (“H-prediabetes”) and by fasting plasma glucose (FPG) (“F-prediabetes”) in regard to prevalence and the influence of potential risk factors, adjusting the latter for confounders.

Methods

A total of 1328 nondiabetic participants aged ≥ 18 years were classified as normoglycemic, H-prediabetic [HbA1c 5.7–6.4% (39–47 mmol/mol)] or F-prediabetic (FPG 5.6–6.9 mmol/L). Multivariable analyses were used to compare the impacts of risk factors on the prevalence of H-prediabetes, F-prediabetes and their conjunctive and disjunctive combinations (“HaF-prediabetes” and “HoF-prediabetes,” respectively).

Results

Some 29.9% of participants were HoF-prediabetic, 21.7% H-prediabetic, 16.3% F-prediabetic and only 8.1% HaF-prediabetic. Whatever the definition of prediabetes, increasing age, fasting insulin and LDL cholesterol were each a risk factor after adjustment for all other variables. Increasing BMI and decreasing mean corpuscular hemoglobin (MCH) were additional risk factors for H-prediabetes; male sex and increasing uric acid for F-prediabetes and increasing BMI for HaF-prediabetes. The participants satisfying the compound condition “hypertension or hyperlipidemia or obesity or hyperuricemia” (59.9% of the whole study group) included 83.1% of all subjects with HoF-prediabetes.

Conclusions

In this population, the most sensitive risk factor for detection of prediabetes was age, followed by fasting insulin, LDL cholesterol, BMI, MCH, male sex and uric acid, with differences depending on the definition of prediabetes. MCH, an indirect measure of erythrocyte survival, significantly influences the prevalence of HbA1c-defined prediabetes. This study suggests that screening of individuals with selected risk factors may identify a high proportion of prediabetic persons.
Appendix
Available only for authorised users
Literature
1.
go back to reference American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl. 1):S62–S69CrossRef American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl. 1):S62–S69CrossRef
2.
3.
go back to reference American Diabetes Association (2017) Classification and diagnosis of diabetes mellitus. Secion 2. In Standards of Medical Care in Diabetes-2017. Diabetes Care 40(1):S11–S24CrossRef American Diabetes Association (2017) Classification and diagnosis of diabetes mellitus. Secion 2. In Standards of Medical Care in Diabetes-2017. Diabetes Care 40(1):S11–S24CrossRef
4.
go back to reference Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403CrossRef Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403CrossRef
5.
go back to reference Goldstein DE, Little RR, Lorenz RA et al (2004) Tests of glycemia in diabetes. Diabetes Care 27:1761–1773CrossRef Goldstein DE, Little RR, Lorenz RA et al (2004) Tests of glycemia in diabetes. Diabetes Care 27:1761–1773CrossRef
6.
go back to reference Sacks DB (2011) A1C versus glucose testing: a comparison. Diabetes Care 34:518–523CrossRef Sacks DB (2011) A1C versus glucose testing: a comparison. Diabetes Care 34:518–523CrossRef
7.
go back to reference Warren B, Pankow JS, Matsushita K et al (2017) Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol 5(1):34–42CrossRef Warren B, Pankow JS, Matsushita K et al (2017) Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol 5(1):34–42CrossRef
8.
go back to reference Mann DM, Carson AP, Shimbo D, Fonseca V, Fox CS, Muntner P (2010) Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults. Diabetes Care 33:2190–2195CrossRef Mann DM, Carson AP, Shimbo D, Fonseca V, Fox CS, Muntner P (2010) Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults. Diabetes Care 33:2190–2195CrossRef
9.
go back to reference Olson DE, Rhee MK, Herrick K, Ziemer DC, Twombly JG, Phillips LS (2010) Screening for diabetes and pre-diabetes with proposed HbA1C-based diagnostic criteria. Diabetes Care 33:2184–2189CrossRef Olson DE, Rhee MK, Herrick K, Ziemer DC, Twombly JG, Phillips LS (2010) Screening for diabetes and pre-diabetes with proposed HbA1C-based diagnostic criteria. Diabetes Care 33:2184–2189CrossRef
10.
go back to reference James C, Bullard KM, Rolka DB et al (2011) Implications of alternative definitions of prediabetes for prevalence in US adults. Diabetes Care 34:387–391CrossRef James C, Bullard KM, Rolka DB et al (2011) Implications of alternative definitions of prediabetes for prevalence in US adults. Diabetes Care 34:387–391CrossRef
11.
go back to reference Nowicka P, Santoro N, Liu H et al (2011) Utility of hemoglobin HbA1C for diagnosing prediabetes and diabetes in obese children and adolescents. Diabetes Care 34:1306–1311CrossRef Nowicka P, Santoro N, Liu H et al (2011) Utility of hemoglobin HbA1C for diagnosing prediabetes and diabetes in obese children and adolescents. Diabetes Care 34:1306–1311CrossRef
12.
go back to reference Pinelli NR, Jantz AS, Martin ET, Jaber LA (2011) Sensitivity and specificity of glycated haemoglobin as a diagnostic test for diabetes and prediabetes in Arabs. J Clin Endocrinol Metab 96:E1680–E1683CrossRef Pinelli NR, Jantz AS, Martin ET, Jaber LA (2011) Sensitivity and specificity of glycated haemoglobin as a diagnostic test for diabetes and prediabetes in Arabs. J Clin Endocrinol Metab 96:E1680–E1683CrossRef
13.
go back to reference Saukkonen T, Cederberg H, Jokelainen J et al (2011) Limited overlap between intermediate hyperglycemia as defined by A1C 5.7–6.4%, impaired fasting glucose, and impaired glucose tolerance. Diabetes Care 34(10):2314–2316CrossRef Saukkonen T, Cederberg H, Jokelainen J et al (2011) Limited overlap between intermediate hyperglycemia as defined by A1C 5.7–6.4%, impaired fasting glucose, and impaired glucose tolerance. Diabetes Care 34(10):2314–2316CrossRef
14.
go back to reference Tankova T, Chakarova N, Dakovska L, Atanassova I (2012) Assessment of HbA1c as a diagnostic tool in diabetes and prediabetes. Acta Diabetol 49:371–378CrossRef Tankova T, Chakarova N, Dakovska L, Atanassova I (2012) Assessment of HbA1c as a diagnostic tool in diabetes and prediabetes. Acta Diabetol 49:371–378CrossRef
15.
go back to reference Sumner AE, Duong MT, Aldana PC et al (2016) A1C combined with glycated albumin improves detection of prediabetes in Africans: the Africans in America Study. Diabetes Care 39:271–277PubMed Sumner AE, Duong MT, Aldana PC et al (2016) A1C combined with glycated albumin improves detection of prediabetes in Africans: the Africans in America Study. Diabetes Care 39:271–277PubMed
16.
go back to reference Heianza Y, Hara S, Arase Y et al (2011) HbA1c 5.7–6.4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study. Lancet 378:147–155CrossRef Heianza Y, Hara S, Arase Y et al (2011) HbA1c 5.7–6.4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study. Lancet 378:147–155CrossRef
17.
go back to reference Lipska KJ, Inzucchi SE, Van Ness PH et al (2013) Elevated HbA1c and fasting plasma glucose in predicting diabetes incidence among older adults. Are two better than one? Diabetes Care 36:3923–3929CrossRef Lipska KJ, Inzucchi SE, Van Ness PH et al (2013) Elevated HbA1c and fasting plasma glucose in predicting diabetes incidence among older adults. Are two better than one? Diabetes Care 36:3923–3929CrossRef
18.
go back to reference Eastwood SV, Tillin T, Sattar N, Forouhi NG, Hughes AD, Chaturvedi N (2015) Associations between prediabetes, by three different diagnostic criteria, and incident CVD differ in south Asians and Europeans. Diabetes Care 38:2325–2332CrossRef Eastwood SV, Tillin T, Sattar N, Forouhi NG, Hughes AD, Chaturvedi N (2015) Associations between prediabetes, by three different diagnostic criteria, and incident CVD differ in south Asians and Europeans. Diabetes Care 38:2325–2332CrossRef
19.
go back to reference Diabetes Prevention Program Research Group (2015) HbA1c as a predictor of diabetes and as an outcome in the diabetes prevention program: a randomized clinical trial. Diabetes Care 38:51–58CrossRef Diabetes Prevention Program Research Group (2015) HbA1c as a predictor of diabetes and as an outcome in the diabetes prevention program: a randomized clinical trial. Diabetes Care 38:51–58CrossRef
20.
go back to reference Anjana RM, Shanthi Rani CS, Deepa M et al (2015) Incidence of diabetes and prediabetes and predictors of progression among Asian Indians: 10-year follow-up of the Chennai Urban Rural Epidemiology Study (CURES). Diabetes Care 38:1441–1448CrossRef Anjana RM, Shanthi Rani CS, Deepa M et al (2015) Incidence of diabetes and prediabetes and predictors of progression among Asian Indians: 10-year follow-up of the Chennai Urban Rural Epidemiology Study (CURES). Diabetes Care 38:1441–1448CrossRef
21.
go back to reference Gude F, Díaz-Vidal P, Rúa-Pérez C et al (2017) Glycaemic variability and its association with demographics and lifestyles in a general adult population. J Diabetes Sci Technol 11:780–790CrossRef Gude F, Díaz-Vidal P, Rúa-Pérez C et al (2017) Glycaemic variability and its association with demographics and lifestyles in a general adult population. J Diabetes Sci Technol 11:780–790CrossRef
22.
go back to reference Hoelzel W, Weykamp C, Jeppsson JO et al (2004) IFCC reference system for measurement of haemoglobin HbA 1C in human blood and the National Standardization Schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 50:166–174CrossRef Hoelzel W, Weykamp C, Jeppsson JO et al (2004) IFCC reference system for measurement of haemoglobin HbA 1C in human blood and the National Standardization Schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 50:166–174CrossRef
23.
go back to reference Lipska KJ, De Reheneire N, Van Ness PT et al (2010) Identifying dysglycaemic states in older adults: implications of the emerging use of haemoglobin HbA1c. J Clin Endocrinol Metab 95:5289–5295CrossRef Lipska KJ, De Reheneire N, Van Ness PT et al (2010) Identifying dysglycaemic states in older adults: implications of the emerging use of haemoglobin HbA1c. J Clin Endocrinol Metab 95:5289–5295CrossRef
24.
go back to reference Mostafa SA, Davies MJ, Webb D et al (2010) The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting type 2 diabetes mellitus. Diabet Med 27:762–769CrossRef Mostafa SA, Davies MJ, Webb D et al (2010) The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting type 2 diabetes mellitus. Diabet Med 27:762–769CrossRef
25.
go back to reference Cosson E, Chiheb S, Cussac-Pillegand C et al (2013) Haemoglobin glycation may partly explain the discordance between HbA1c measurement and oral glucose tolerance test to diagnose dysglycaemia in overweight/obese subjects. Diabetes Metab 39:118–125CrossRef Cosson E, Chiheb S, Cussac-Pillegand C et al (2013) Haemoglobin glycation may partly explain the discordance between HbA1c measurement and oral glucose tolerance test to diagnose dysglycaemia in overweight/obese subjects. Diabetes Metab 39:118–125CrossRef
26.
go back to reference Li J, Ma H, Na L et al (2015) Increased Hemoglobin A1c threshold for prediabetes remarkably improving the agreement between A1c and oral glucose tolerance test criteria in obese population. J Clin Endocrinol Metab 100:1997–2005CrossRef Li J, Ma H, Na L et al (2015) Increased Hemoglobin A1c threshold for prediabetes remarkably improving the agreement between A1c and oral glucose tolerance test criteria in obese population. J Clin Endocrinol Metab 100:1997–2005CrossRef
27.
go back to reference Rosella LC, Lebenbaum M, Fitzpatrick T, Zuk A, Booth GL (2015) The prevalence of undiagnosed and prediabetes diabetes in Canada (2007–2011) according to fasting plasma glucose and HbA1c screening criteria. Diabetes Care 38:1299–1305CrossRef Rosella LC, Lebenbaum M, Fitzpatrick T, Zuk A, Booth GL (2015) The prevalence of undiagnosed and prediabetes diabetes in Canada (2007–2011) according to fasting plasma glucose and HbA1c screening criteria. Diabetes Care 38:1299–1305CrossRef
28.
go back to reference Ho-Pham LT, Do TT, Campbell LV, Nguyen TV (2016) HbA1c-based classification reveals epidemic of diabetes and prediabetes in Vietnam. Diabetes Care 39:e93–e94CrossRef Ho-Pham LT, Do TT, Campbell LV, Nguyen TV (2016) HbA1c-based classification reveals epidemic of diabetes and prediabetes in Vietnam. Diabetes Care 39:e93–e94CrossRef
29.
go back to reference Hashimoto Y, Futamura A, Ikushima M (1995) Effect of aging on HbA1c in a working male Japanese population. Diabetes Care 18:1337–1340CrossRef Hashimoto Y, Futamura A, Ikushima M (1995) Effect of aging on HbA1c in a working male Japanese population. Diabetes Care 18:1337–1340CrossRef
30.
go back to reference Nuttall QF (1999) Effect of age on percentage of hemoglobin A1c and the percentage of total glycohemoglobin in non-diabetic persons. J Lab Clin Med 134:451–453CrossRef Nuttall QF (1999) Effect of age on percentage of hemoglobin A1c and the percentage of total glycohemoglobin in non-diabetic persons. J Lab Clin Med 134:451–453CrossRef
31.
go back to reference Pani LN, Korenda L, Meigs JB et al (2008) Effect of aging on A1C levels in individuals without diabetes. Evidence from the Framingham offspring study and the National Health and Nutrition Examination Survey 2001–2004. Diabetes Care 31:1991–1996CrossRef Pani LN, Korenda L, Meigs JB et al (2008) Effect of aging on A1C levels in individuals without diabetes. Evidence from the Framingham offspring study and the National Health and Nutrition Examination Survey 2001–2004. Diabetes Care 31:1991–1996CrossRef
32.
go back to reference Selvin E, Zhu H, Brancati FL (2009) Elevated A1C in adults without a history of diabetes in the U.S. Diabetes Care 32:828–833CrossRef Selvin E, Zhu H, Brancati FL (2009) Elevated A1C in adults without a history of diabetes in the U.S. Diabetes Care 32:828–833CrossRef
33.
go back to reference Rodriguez-Segade S, Rodriguez Garcia J, Garcia-Lopez JM et al (2016) Impact of mean cell hemoglobin on HbA1c-defined glycemia status. Clin Chem 62:1570–1578CrossRef Rodriguez-Segade S, Rodriguez Garcia J, Garcia-Lopez JM et al (2016) Impact of mean cell hemoglobin on HbA1c-defined glycemia status. Clin Chem 62:1570–1578CrossRef
34.
go back to reference Lorenzo C, Wagenknecht LE, Hanley AJG, Rewers MJ, Karter AJ, Haffner SM (2010) A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors. Diabetes Care 33:2104–2109CrossRef Lorenzo C, Wagenknecht LE, Hanley AJG, Rewers MJ, Karter AJ, Haffner SM (2010) A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors. Diabetes Care 33:2104–2109CrossRef
35.
go back to reference International Expert Committee (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:1327–1334CrossRef International Expert Committee (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:1327–1334CrossRef
Metadata
Title
Prediabetes defined by HbA1c and by fasting glucose: differences in risk factors and prevalence
Authors
Santiago Rodriguez-Segade
Javier Rodriguez
Félix Camiña
Luís Sanmartín-Portas
Josefa Gerpe-Jamardo
Marcos Pazos-Couselo
Jose M. García-López
Manuela Alonso-Sampedro
Arturo González-Quintela
Francisco Gude
Publication date
01-09-2019
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 9/2019
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-019-01342-5

Other articles of this Issue 9/2019

Acta Diabetologica 9/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.